Pharvaris Nv

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$36.37

-1.63 (-4.29%)

As of Sep 20, 10:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target -38.4% upside

Low Target $12.72

Average Target $22.40

High Target $29.92

Current Price $36.37

Current
$36.37

Target
$22.40

$12.72 $22.40 avg $29.92

Scenario Analysis

Bear Case

$12.72

-65.0%

Low target

Base Case

$22.40

-38.4%

Avg target

Bull Case

$29.92

+-17.7%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$43.25

-15.9% from high

52-Week Low

$20.65

+76.1% from low

Target vs 52W High

$22.40

-48.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+14.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.2%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+6.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+194.2%